Bianchetti & Minoja With Trevisan & Cuonzo Ips patent opposition analysis

The comprehensive analysis of Bianchetti & Minoja With Trevisan & Cuonzo Ips opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Bianchetti & Minoja With Trevisan & Cuonzo Ips

Patent NumberTitleApplicantOpposition DateOpposition Company
Magnolia Bark Extract As A Hydrophobic Ligand For Preferential Removal Of Gram Negative Bacteria From The Oral CavityWM WRIGLEY JROct 6, 2021PERFETTI VAN MELLE
An Inhalable MedicamentTEVA PHARMACEUTICALSFeb 6, 2020CHIESI FARMACEUTICI
Solid State Forms Of SelexipagTEVA PHARMACEUTICALSFeb 6, 2020CHIESI FARMACEUTICI
New Process For The Synthesis Of 1-(2-((2,4-Dimethylphenyl)Thio)Phenyl)PiperazineLEK PHARMACEUTICALS DDDec 5, 2019DIPHARMA FRANCIS

Top companies who are the clients of Bianchetti & Minoja With Trevisan & Cuonzo Ips